BACTERIOLOGICAL, PHARMACOKINETIC AND CLINICAL STUDIES ON ME 1207 IN OTORHINOLARYNGOLOGICAL INFECTION

Bacteriological, pharmacokinetic and clinical studies were carried out with ME 1207 in otorhinolaryngological infection. The results were as follows. 1. The antibacterial activity of ME 1206 against Staphylococcus aureus (15 strains) was superior to that of cefaclor and cefixime, and against Pseudom...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 40; no. Supplement2; pp. 636 - 642
Main Authors Miyamoto, Naoya, Kobayashi, Takehiro, Yamamoto, Shinichiro, Baba, Shunkichi, Ito, Haruo, Tonai, Akira, Isaji, Hiroko, Shimada, Junichiro, Nagata, Soichiro
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1992
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bacteriological, pharmacokinetic and clinical studies were carried out with ME 1207 in otorhinolaryngological infection. The results were as follows. 1. The antibacterial activity of ME 1206 against Staphylococcus aureus (15 strains) was superior to that of cefaclor and cefixime, and against Pseudomonas aeruginosa (14 strains) was excellent compared to the other two drug. 2. The concentration of ME 1206 was 0.08μg/g in the tonsils, 0.16μg/g in the mucous membrane of the maxillary sinus and 0.2μg/g in the mucous membrane of the ethmoidal sinus. 3. The overall clinical efficacy of ME 1207 was 70.8%. There were no abnormal laboratory findings and eruption was observed in one case.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.40.Supplement2_636